Matches in Wikidata for { <http://www.wikidata.org/entity/Q65399930> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q65399930 description "clinical trial" @default.
- Q65399930 description "ensayu clínicu" @default.
- Q65399930 description "klinisch onderzoek" @default.
- Q65399930 description "клінічне випробування" @default.
- Q65399930 description "կլինիկական փորձարկում" @default.
- Q65399930 name "18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment" @default.
- Q65399930 name "18F Fluciclovine" @default.
- Q65399930 type Item @default.
- Q65399930 label "18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment" @default.
- Q65399930 label "18F Fluciclovine" @default.
- Q65399930 prefLabel "18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment" @default.
- Q65399930 prefLabel "18F Fluciclovine" @default.
- Q65399930 P1132 Q65399930-0FC42FAE-5BCF-4E06-A6ED-EC26CF307331 @default.
- Q65399930 P1476 Q65399930-BDA36A93-3CF0-47A1-8C9F-320FB9C58471 @default.
- Q65399930 P17 Q65399930-873EA2F4-D01C-4B31-90CF-198051B90AA9 @default.
- Q65399930 P1813 Q65399930-FE5C3273-86A7-46EA-B0EC-06A2C3D5DB59 @default.
- Q65399930 P2899 Q65399930-F6871243-EEA3-4CF9-82AE-769CEE342D1F @default.
- Q65399930 P3098 Q65399930-2F26B5E4-AB54-4A64-AA45-490DF36F2D8F @default.
- Q65399930 P31 Q65399930-ED61A13B-FDC7-459C-9092-D198C1C762C7 @default.
- Q65399930 P580 Q65399930-17DFA2E8-8630-48B3-B051-058560659E5E @default.
- Q65399930 P582 Q65399930-0222F13C-153D-487D-A0EE-CC9AB5C75AA6 @default.
- Q65399930 P6099 Q65399930-AD3C9FD1-EE62-4784-90BD-4A1B0960548C @default.
- Q65399930 P6153 Q65399930-1A4C1EA2-DD89-47BD-85A8-5645F0D96B81 @default.
- Q65399930 P6153 Q65399930-24D19164-5C48-47A7-91A2-9113C9AB3589 @default.
- Q65399930 P6153 Q65399930-3B5496CF-E070-49D5-857E-F1BA77B208DD @default.
- Q65399930 P6153 Q65399930-539BAEF1-D48B-43EF-8674-896C83A23C73 @default.
- Q65399930 P6153 Q65399930-679D0D62-A292-4900-B0F5-B1B08A482E9E @default.
- Q65399930 P6153 Q65399930-A3EF2C20-78CA-42E6-8291-17FAF082B66C @default.
- Q65399930 P6153 Q65399930-C4B8E449-2852-4BCB-AC3B-55E5C2559901 @default.
- Q65399930 P6153 Q65399930-CAFE96C8-EB26-4B5C-BCB9-7E0E7A8E2734 @default.
- Q65399930 P6153 Q65399930-E2DF6AB7-07CE-408D-AFF8-5EAB1EC16F8A @default.
- Q65399930 P6153 Q65399930-E3F812E4-A200-444C-91E9-30F5C0B68B24 @default.
- Q65399930 P8363 Q65399930-77B40586-3256-4881-B661-2CB8029F1F3A @default.
- Q65399930 P1132 "+221" @default.
- Q65399930 P1476 "The Impact of 18F Fluciclovine (FACBC) PET/CT (Positron Emission Computed Tomography) on Management of Patients With Rising PSA (Prostate-specific Antigen) After Initial Prostate Cancer Treatment" @default.
- Q65399930 P17 Q30 @default.
- Q65399930 P1813 "LOCATE" @default.
- Q65399930 P2899 "+18" @default.
- Q65399930 P3098 "NCT02680041" @default.
- Q65399930 P31 Q30612 @default.
- Q65399930 P580 "2016-06-01T00:00:00Z" @default.
- Q65399930 P582 "2017-11-01T00:00:00Z" @default.
- Q65399930 P6099 Q42824827 @default.
- Q65399930 P6153 Q1052562 @default.
- Q65399930 P6153 Q1317143 @default.
- Q65399930 P6153 Q1950740 @default.
- Q65399930 P6153 Q30270066 @default.
- Q65399930 P6153 Q49117 @default.
- Q65399930 P6153 Q501758 @default.
- Q65399930 P6153 Q5123723 @default.
- Q65399930 P6153 Q5476635 @default.
- Q65399930 P6153 Q6694611 @default.
- Q65399930 P6153 Q7972509 @default.
- Q65399930 P8363 Q78089383 @default.